Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN)

$23.79 USD $0.82 (3.57%)
Last Price $23.79
Net Change $0.82 (3.57%)
Bid $0
Ask Price $0
Open Price $23.19
Previous Close Price $22.97
High Price $25.2
Low Price $22.79
Number of Trades 1,530
Volume 219,600
Fifty Two Week High $25.2 (2017-05-26)
Fifty Two Week Low $17 (2017-05-04)
Average Daily Volume 230,500
Share Outstanding 34,230 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $0
Last Quarter EPS $
Market Capitalization $0.81B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 34,230
Inst. Shareholder % 0%
Annual Net Income $0B
TTM Net Profit Margin $100
1-Year Return 35.94%
3-Year Return 35.94%
5-Year Return 35.94%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio
Beta
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.

BHVN News & Stock Updates